Physician profile
Yasser Faraj
NPI 1043848229
$2,939.94
in general payments reported to CMS, 2019-2025
23 companies · $468 in 2025
The $468 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $765 · 2023: $1,052 · 2024: $655 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.10 |
| Education | $179.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $720.46 | 2022-2024 | Blu-U, Odomzo |
| Abbvie INC. | $380.86 | 2022-2024 | |
| Janssen Biotech, INC. | $305.44 | 2023-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $209.63 | 2023-2025 | Dupixent |
| Genzyme Corporation | $207.31 | 2022-2023 | |
| Lilly USA, LLC | $171.39 | 2023-2024 | Olumiant |
| Surgenex LLC | $148.03 | 2025 | Surgraft, Surmatrix, Pellograft |
| Dermavant Sciences, INC. | $145.20 | 2023 | Vtama |
| Ucb, INC. | $118.63 | 2022-2023 | Cimzia |
| Leo Pharma INC. | $90.98 | 2022-2024 | Adbry |
| Kyowa Kirin, INC. | $55.41 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $48.85 | 2023-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $43.58 | 2022-2025 | Nemluvio |
| Incyte Corporation | $42.62 | 2023-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $41.22 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $39.15 | 2023-2024 | Zoryve |
| Biofrontera INC. | $36.95 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.31 | 2023-2025 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.28 | 2023 | Siliq |
| Mimedx Group, INC. | $23.19 | 2025 | |
| Organogenesis INC. | $19.90 | 2025 | Puraply Wound Matrix |
| Mayne Pharma Commercial LLC | $17.03 | 2023 | |
| Biowound Solutions, INC. | $8.52 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasser Faraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.